During the past decade, Hospital Universitario de Canarias conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 49 clinical trials were completed, i.e. on average, 31.2% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 29 clinical trials were completed. i.e. 41.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Canarias" #1 sponsor was "Hoffmann-La Roche" with 34 trials, followed by "PETHEMA Foundation" with 26 trials sponsored, "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored and "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 9 trials sponsored. Other sponsors include 165 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Canarias" #1 collaborator was "AstraZeneca" with 7 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Celgene" with 4 trials as a collaborator. Other collaborators include 164 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Canarias" are "Breast Cancer" (26 trials), "Multiple Myeloma" (17 trials), "Breast Neoplasms" (6 trials), "Rheumatoid Arthritis" (6 trials) and "Advanced Prostate Cancer" (4 trials). Many other conditions were trialed in "Hospital Universitario de Canarias" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Canarias" are "Drug" (185 trials), "Procedure" (18 trials), "Other" (16 trials), "Device" (15 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Cyclophosphamide" (16 trials), "Dexamethasone" (14 trials), "Trastuzumab" (11 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Canarias" are 227 trials for "All" genders, 25 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Canarias". 4 are not yet recruiting, 47 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 126 completed trials in Hospital Universitario de Canarias, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Canarias, 8 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 13 trials that are defined as “Not Applicable".